Brief: Rhythm Biosciences Confirms Expansion Of CE Mark Registration
06/01/2022 01:35
Jan 6 (Reuters) - Rhythm Biosciences Ltd RHY.AX :
* CONFIRMS EXPANSION OF CE MARK REGISTRATION ALLOWING
COLOSTAT TO
BE MARKETED & SOLD WITHIN GREAT BRITAIN & NORTHERN IRELAND.
Source text for Eikon: ID:nASX14jpWg
Further company coverage: RHY.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Biosciences
See all newsBrief: Rhythm Biosciences Says Gavin Fox-Smith Resigns As Chair
Brief: Rhythm Biosciences Announces Appointment Of Non-Executive Directors
Australia's Rhythm Biosciences rises on accelerating commercialisation of cancer test
Brief: Rhythm Biosciences Executes Distribution Agreement For Genetype
Brief: Rhythm Biosciences Seeks Trading Halt